March 13, 2015

An Altarum report found that national health spending increased 5.7% in January 2015 vs. January 2014. 

March 11, 2015

A new MIT study published Wednesday suggests that a more powerful H1N1 influenza strain may be making its way through India. 

March 11, 2015

Mylan launched its fentanyl transdermal system in 37.5-, 62.5- and 87.50-mcg/hr dosage strengths in the United States.

March 10, 2015

Purdue Pharma's Stephen Seid honored with HDMA's 2015 Distribution Management Award for Industry Leadership. 

 

March 10, 2015

Impax Labs completed its acquisition of Tower Holdings (which includes operating subsidiaries CorePharma and Amedra Pharmaceuticals), and Lineage Therapeutics. Impax also announced that it would reshape both the operating and reporting structure of its two divisions.

March 9, 2015

Apple on Monday better enabled medical research with the launch of open source software framework ResearchKit. 

March 6, 2015

The Food and Drug Administration approved Zarxio, making it the first approved biosimilar product in the United States.

March 2, 2015

The implementation of an e-prescribing mandate in New York hits a snag as state legislators agree to a delay.

February 27, 2015

ACIP on Thursday recommended that children ages 6 months and older get an annual influenza vaccine with no preference stated for either the nasal spray vaccine or the flu shot.

February 27, 2015

GlaxoSmithKline expects to complete its Novartis transaction in the week commencing March 2.

February 27, 2015

Nine-in-10 consumers who opted for a needle-free flu shot this season would choose that option again and recommend it to family and friends. 

February 26, 2015

The CDC’s Advisory Committee on Immunization Practices made a unanimous recommendation for use of meningococcal group B vaccines to vaccinate high-risk groups in the United States.

February 26, 2015

Congress introdues legislation to protect FDA user fees from sequestration. 

February 26, 2015

Protein Sciences expanded Flublok distribution through Cardinal, McKesson this week. 

February 26, 2015

A survey found that chronic disease patients who use digital technology to manage their disease state feel "healthier."

 

February 26, 2015

The fixed-combination drug Avycaz was granted priority review by the Food and Drug Administration. 

February 26, 2015

Sanofi expands its portfolio of insulin therapy products with the introduction of the once-daily, long-acting Toujeo. 

February 25, 2015

Diplomat Pharmacy to dispense new multiple myeloma treatment from Novartis. 

February 25, 2015

In 10 years, the percentage of opioid analgesic users who used an opioid analgesic stronger than morphine increased from 17% to 37%, NCHS reported Wednesday. 

February 24, 2015

Shire on Tuesday acquired Meritage, which includes the phase 3-ready compound Oral Budesonide Suspension for the treatment of adolescents and adults with eosinophilic esophagitis.

February 24, 2015

According to the latest Walgreens Flu Index, flu activity is no longer picking up across the West Coast and in Texas. 

February 23, 2015

The Centers for Disease Control and Prevention last week reported several influenza hot spots across the nation. 

February 23, 2015

A centralized notification system for immunization reminders would significantly improve childhood immunization rates, according to a study pubished in  JAMA Pediatrics

February 23, 2015

Valeant Pharmaceuticals bolsters GI franchise in a $14.5 billion deal to acquire Salix Pharmaceuticals.